Valuation Sanofi Börse Stuttgart

Stocks

Market Closed - Börse Stuttgart 23:55:37 09/10/2026 +04			5-day change	1st Jan Change
35.60 ^EUR	-0.56%		+0.56%	-12.75%

10-07	Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule	MT
10-07	European Equities Traded in US as ADRs Fall in Wednesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,194	112,665	112,549	116,968	100,655	85,686	-	-
Change	-	1.32%	-0.1%	3.93%	-13.95%	-14.87%	-	-
Enterprise Value (EV) ¹	121,177	119,102	120,342	125,740	111,663	97,022	93,690	90,858
Change	-	-1.71%	1.04%	4.49%	-11.2%	-13.11%	-3.43%	-3.02%
P/E	17.8x	16.7x	20.8x	20.4x	12.9x	11.6x	10x	8.62x
PBR	1.62x	1.5x	1.52x	1.51x	1.41x	1.16x	1.09x	1.04x
PEG	-	2.07x	-1.1x	3.14x	0.3x	-3.01x	0.6x	0.5x
Capitalization / Revenue	2.94x	2.62x	2.61x	2.85x	2.31x	1.81x	1.7x	1.61x
EV / Revenue	3.21x	2.77x	2.79x	3.06x	2.56x	2.05x	1.86x	1.71x
EV / EBITDA	9.95x	8.14x	8.44x	9.76x	8.22x	6.56x	5.95x	5.31x
EV / EBIT	11.3x	9.13x	9.5x	11.1x	9.19x	7.39x	6.78x	6.03x
EV / FCF	15x	14x	14.2x	21.1x	13.8x	11.8x	10.4x	9.06x
FCF Yield	6.68%	7.12%	7.04%	4.74%	7.24%	8.48%	9.59%	11%
Dividend per Share ²	3.33	3.56	3.76	3.92	4.12	4.256	4.502	4.801
Rate of return	3.76%	3.96%	4.19%	4.18%	4.98%	5.95%	6.3%	6.71%
EPS ²	4.97	5.37	4.31	4.59	6.4	6.153	7.144	8.3
Distribution rate	67%	66.3%	87.2%	85.4%	64.4%	69.2%	63%	57.8%
Net sales ¹	37,761	42,997	43,070	41,081	43,626	47,346	50,465	53,242
EBITDA ¹	12,183	14,627	14,259	12,889	13,583	14,789	15,745	17,124
EBIT ¹	10,714	13,040	12,670	11,343	12,149	13,136	13,819	15,078
Net income ¹	6,223	6,720	5,400	5,744	7,813	7,298	8,814	10,260
Net Debt ¹	9,983	6,437	7,793	8,772	11,008	11,336	8,004	5,173
Reference price ²	88.58	89.84	89.76	93.74	82.72	71.52	71.52	71.52
Nbr of stocks (in thousands)	1,255,293	1,254,060	1,253,891	1,247,793	1,216,810	1,198,069	-	-
Announcement Date	04/02/22	03/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.55x	12.18x	25.21x	0.58%	1,051B
JOHNSON & JOHNSON	29x	6.42x	18.31x	2.04%	630B
ABBVIE INC.	35.19x	8.13x	16.76x	2.51%	489B
MERCK & CO., INC.	111.24x	5.93x	25.27x	2.34%	359B
ROCHE HOLDING AG	19.31x	4.72x	11.72x	2.8%	344B
NOVARTIS AG	20.06x	5.27x	12.98x	3.02%	272B
ASTRAZENECA PLC	20.57x	4.21x	12.06x	2.1%	246B
AMGEN INC.	26.34x	6.83x	12.21x	2.43%	224B
GILEAD SCIENCES, INC.	-45.84x	6.75x	26.31x	2.18%	187B
Average	27.72x	6.72x	17.87x	2.22%	422.63B
Weighted average by Cap.	32.91x	7.85x	19.33x	1.9%